There are 805 resources available
180P - Evaluation of a minimally invasive sponge cytology sampling for screening of esophageal squamous cell carcinoma and gastric cardia adenocarcinoma
Presenter: Zhiyuan Fan
Session: Poster Display session
Resources:
Abstract
181P - The efficacy, safety and cell-free DNA of perioperative leucovorin, oxaliplatin, docetaxel and S-1 (LOTS) for locally advanced gastric or gastroesophageal junction adenocarcinoma: A prospective phase II trial
Presenter: Chih Chieh Yen
Session: Poster Display session
Resources:
Abstract
182P - Real-world treatment (Tx) patterns in patients (pts) with HER2-positive locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (HER2+ aGC/GEJC) in East Asia (HER2+ GASTA)
Presenter: Do-Youn Oh
Session: Poster Display session
Resources:
Abstract
183P - Response of gastric adenocarcinoma to neoadjuvant chemotherapy with respect to the presence or absence of HER2 overexpression: A prospective observational study
Presenter: Pratap Deb
Session: Poster Display session
Resources:
Abstract
186P - Efficacy and safety between weekly and monthly neoadjuvant cisplatin and fluorouracil chemoradiotherapy regimens in locoregional esophageal squamous cell carcinoma
Presenter: Cheng-Lun Lai
Session: Poster Display session
Resources:
Abstract
187P - Effectiveness, safety, and patterns of use of camrelizumab in advanced esophageal cancer: An individual patient data (IPD) pooled analysis of 987 patients from three prospective observational cohort studies
Presenter: Zhihao Lu
Session: Poster Display session
Resources:
Abstract
188P - The impact of pathological regression of primary tumor and lymph node on recurrence and survival in patients with locally advanced esophageal squamous cell carcinoma following neoadjuvant chemo-immunotherapy
Presenter: Yixin Li
Session: Poster Display session
Resources:
Abstract
189P - Superior anti-tumor activity of NC18, a novel HER2-targeting ADC, against enhertu-resistant CDX model
Presenter: Li Zhi
Session: Poster Display session
Resources:
Abstract
190P - Tislelizumab as a treatment for Esophageal carcinoma: A systematic review and meta-analysis
Presenter: Hashim Talib Hashim
Session: Poster Display session
Resources:
Abstract
191P - Real-world data of non-metastatic carcinoma esophagus patients treated with multimodality treatment in a resource constrained setting from South India
Presenter: Ravi Teja Matta
Session: Poster Display session
Resources:
Abstract